Literature DB >> 17415778

Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.

Steven T Okino1, Deepa Pookot, Shahana Majid, Hong Zhao, Long-Cheng Li, Robert F Place, Rajvir Dahiya.   

Abstract

Glutathione-S-transferases (GSTs) are metabolic enzymes that help detoxify and eliminate harmful chemicals. In prostate tumors, expression of GST pi (encoded by GSTP1) is frequently lost because of promoter hypermethylation. Here we analyze the native GSTP1 promoter in cancerous and noncancerous human prostate cells to identify structural features associated with its cancer-related transcriptional silencing. We find that in noncancerous prostate cells (RWPE-1 and PWR-1E) GSTP1 is constitutively expressed, not methylated, highly accessible, bound by transcription factors and associated with histones with activating modifications (histone H3 methylated at lysine 4 and acetylated histones H3 and H4). In contrast, in cancerous prostate cells (LNCaP) GSTP1 is not expressed, extensively methylated, inaccessible, lacks bound transcription factors and is not associated with histones with activating modifications. We do not detect significant levels of histones with repressive modifications (histone H3 methylated at lysine 9 or 27) on GSTP1 in any cell line indicating that they are not associated with cancer-related GSTP1 silencing. Treatment of LNCaP cells with 5-azacytidine restores activating histone modifications on GSTP1 and reactivates transcription. We conclude that, in the process of prostate carcinogenesis, activating histone modifications on GSTP1 are lost and the DNA becomes methylated and inaccessible resulting in transcriptional silencing. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415778     DOI: 10.1002/mc.20313

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  10 in total

1.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

Review 2.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

3.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.

Authors:  Nong Xiang; Rui Zhao; Guoqing Song; Weixiong Zhong
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

4.  Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.

Authors:  Mitali Pandey; Sanjeev Shukla; Sanjay Gupta
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

5.  Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line.

Authors:  Ponpat Intarasunanont; Panida Navasumrit; Somchamai Waraprasit; Krittinee Chaisatra; William A Suk; Chulabhorn Mahidol; Mathuros Ruchirawat
Journal:  Environ Health       Date:  2012-05-02       Impact factor: 5.984

6.  Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.

Authors:  Zhihui Wang; Wei He; Guanrui Yang; Junsheng Wang; Zhong Wang; Jahn M Nesland; Ruth Holm; Zhenhe Suo
Journal:  BMC Cancer       Date:  2010-07-05       Impact factor: 4.430

7.  GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome.

Authors:  Dongdong Liu; Bangwei Che; Pan Chen; Jun He; Yi Mu; Kehang Chen; Wenjun Zhang; Shenghan Xu; Kaifa Tang
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

8.  The use of multiple displacement amplified DNA as a control for methylation specific PCR, pyrosequencing, bisulfite sequencing and methylation-sensitive restriction enzyme PCR.

Authors:  Simon Hughes; J Louise Jones
Journal:  BMC Mol Biol       Date:  2007-10-16       Impact factor: 2.946

9.  Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.

Authors:  Rui Henrique; Ana Isabel Oliveira; Vera L Costa; Tiago Baptista; Ana Teresa Martins; António Morais; Jorge Oliveira; Carmen Jerónimo
Journal:  BMC Genomics       Date:  2013-12-17       Impact factor: 3.969

Review 10.  Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis.

Authors:  Michael Schnekenburger; Tommy Karius; Marc Diederich
Journal:  Front Pharmacol       Date:  2014-07-16       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.